Article
Targeted Delivery of Doxorubicin to Mitochondria
16 Apr 2013
Abstract excerpt
Several families of highly effective anticancer drugs are selectively toxic to cancer cells because they disrupt nucleic acid synthesis in the nucleus. Much less is known, however, about whether interfering with nucleic acid synthesis in the mitochondria would have significant cellular effects. In this study, we explore this with a mitochondrially targeted form of the anticancer drug doxorubicin, which inhibits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
